Immutep (Germany) Performance
| YP1B Stock | 0.19 0.02 11.76% |
The company retains a Market Volatility (i.e., Beta) of 1.1, which attests to a somewhat significant risk relative to the market. Immutep returns are very sensitive to returns on the market. As the market goes up or down, Immutep is expected to follow. At this point, Immutep has a negative expected return of -0.0739%. Please make sure to check out Immutep's potential upside, kurtosis, and the relationship between the maximum drawdown and skewness , to decide if Immutep performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Immutep has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Immutep is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors. ...more
| Begin Period Cash Flow | 60.6 M | |
| Free Cash Flow | -30.3 M |
Immutep |
Immutep Relative Risk vs. Return Landscape
If you would invest 22.00 in Immutep on August 27, 2024 and sell it today you would lose (3.00) from holding Immutep or give up 13.64% of portfolio value over 90 days. Immutep is generating negative expected returns and assumes 5.645% volatility on return distribution over the 90 days horizon. Simply put, 50% of stocks are less volatile than Immutep, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Immutep Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Immutep's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Immutep, and traders can use it to determine the average amount a Immutep's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0131
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | YP1B |
Estimated Market Risk
| 5.65 actual daily | 50 50% of assets are less volatile |
Expected Return
| -0.07 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.01 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Immutep is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Immutep by adding Immutep to a well-diversified portfolio.
Immutep Fundamentals Growth
Immutep Stock prices reflect investors' perceptions of the future prospects and financial health of Immutep, and Immutep fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Immutep Stock performance.
| Current Valuation | 135.66 M | |||
| Price To Book | 2.99 X | |||
| Price To Sales | 938.07 X | |||
| Revenue | 170.37 K | |||
| EBITDA | (32.12 M) | |||
| Total Debt | 1.45 M | |||
| Cash Flow From Operations | (43.94 M) | |||
| Total Asset | 102.17 M | |||
About Immutep Performance
Assessing Immutep's fundamental ratios provides investors with valuable insights into Immutep's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Immutep is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
Things to note about Immutep performance evaluation
Checking the ongoing alerts about Immutep for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Immutep help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Immutep generated a negative expected return over the last 90 days | |
| Immutep has high historical volatility and very poor performance | |
| Immutep has some characteristics of a very speculative penny stock | |
| The company reported the revenue of 170.37 K. Net Loss for the year was (32.21 M) with loss before overhead, payroll, taxes, and interest of (3.41 M). | |
| Immutep generates negative cash flow from operations |
- Analyzing Immutep's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Immutep's stock is overvalued or undervalued compared to its peers.
- Examining Immutep's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Immutep's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Immutep's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Immutep's stock. These opinions can provide insight into Immutep's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Immutep Stock Analysis
When running Immutep's price analysis, check to measure Immutep's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immutep is operating at the current time. Most of Immutep's value examination focuses on studying past and present price action to predict the probability of Immutep's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immutep's price. Additionally, you may evaluate how the addition of Immutep to your portfolios can decrease your overall portfolio volatility.